The Egyptian Journal of Internal Medicine
Cure8 research brief
Why This Matters
People with IBD may be concerned about liver fat and metabolic liver disease. This study examines how common MASLD is in IBD patients versus controls and evaluates non‑invasive tests (FibroScan CAP and HSI) used to detect steatosis.
Who Should Pay Attention
Clinicians managing IBD patients, gastroenterologists, hepatologists, researchers studying IBD–liver comorbidity, and adult patients with IBD interested in liver health.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This abstract reports a case–control study from a single center comparing prevalence of metabolic dysfunction‑associated steatotic liver disease (MASLD) in 54 patients with inflammatory bowel disease (mostly ulcerative colitis) and 51 healthy controls.
Participants had history/clinical assessment, labs, abdominal ultrasound, and FibroScan measurement of Controlled Attenuation Parameter (CAP). The authors found lower MASLD/steatosis prevalence in the IBD group versus controls and that CAP performed better than the Hepatic Steatosis Index (HSI) for detecting steatosis in this sample.
The study suggests metabolic risk factors, not IBD severity, were associated with MASLD; no significant link was seen between disease severity and steatosis. The authors note cautious interpretation because of sample size and differences in metabolic/anthropometric profiles between groups.
This summary is grounded in the article abstract (structured content depth: abstract) and does not represent review of the full paper.
Keep In Mind
Results come from a single‑center case–control study with modest sample size and imbalance in metabolic risk factors between groups; the abstract notes cautious interpretation. Structured content depth is abstract, so details beyond the abstract were not reviewed.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationThe Egyptian Journal of Internal Medicine
AuthorsTasneem Gaber Hussein Abdelazeem, Sayed Ahmed Moawad Saad, Essam Ali Hassan Soliman +2 more
InstitutionFayoum University
Study typeArticle
Indexed viaOpenAlex
Source typeResearch paper
PublishedNov 4, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Relationship between vitamin D serum concentration and inflammatory bowel disease demographics
Vitamin D deficiency was very common in this IBD cohort and was linked to Crohn’s disease and female sex, which may matter because deficiency can affect bone health and immune regulation in people with IBD.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Retinal microvascular alterations detected by optical coherence tomography angiography in patients with inflammatory bowel disease.
IBD may involve small-vessel changes beyond the gut. If reproducible, retinal microvascular alterations detectable by OCTA could offer a non-invasive window into systemic microvascular involvement in IBD.
Crohn᾿s Disease and Ulcerative Colitis: The Role of Endoscopic, Hemogram-derived, Nutritional, and Hepatic Scores
Non-invasive biomarkers that reflect mucosal inflammation and systemic disease activity could help reduce reliance on frequent endoscopy and guide monitoring for people with Crohn’s disease or ulcerative colitis.